| 摘要 |
<p>The invention provides an in vitro method for predicting clinical outcome of a patient affected with breast carcinoma, which method comprises determining the expression of proteins including P13K, Moesin, pAKT, and/or pMAP-K in a biological sample of said patient.</p> |
